This article discusses research findings on how pharmacological activation of kappa opioid receptors in the brain's nucleus accumbens core and ventral tegmental area can increase the negative effects associated with nicotine use.
Understanding these mechanisms can help inform strategies to prevent or treat nicotine dependence by targeting specific brain pathways involved in addiction.